Study: Sperm Banks Unpopular With Patients
Posted on: Thursday, 5 October 2006, 12:00 CDT
Canadian researchers say they found sperm banks are unpopular, even with cancer patients facing treatments that might make them infertile.
The study led by McGill University Health Center researcher Dr. Peter Chan highlights the need to improve doctor-patient communication about the benefits of sperm banking and the need for accurate and personalized information about the high risk of infertility associated with treatment for testicular cancer and Hodgkin's lymphoma.
Testicular cancer and Hodgkin's lymphoma are among the most common malignancies to affect young men of reproductive age. Testicular cancer accounts for over 25 percent of all cancers diagnosed in men aged 20-24 years, and Hodgkin's lymphoma accounts for about 15 percent in the same age group, said Chan, director of male reproductive medicine at the McGill and senior author of the study. Sperm banking is the best hope for cancer patients that may wish to father children in the future.
The research is discussed in a recent issue of the journal Human Reproduction.
Source: United Press International
Related Articles
- Cephalon Announces Positive Results From Its Pivotal Study of TREANDA in Patients With Non-Hodgkin's Lymphoma
- NCCN Updates Non-Hodgkin's Lymphoma Guidelines
- Favrille Announces Data From Phase 2 Clinical Trial of FavId for Indolent B-Cell Non-Hodgkin's Lymphoma in Europe
- Hepatitis C May Boost Risk for Non-Hodgkin's Lymphoma
- Seattle Genetics Initiates Phase II Clinical Trial of SGN-40 for the Treatment of Non-Hodgkin's Lymphoma
- Seattle Genetics Reports Positive Phase I Clinical Trial Results With SGN-40 in Non-Hodgkin's Lymphoma and Multiple Myeloma at ASH
- FDA Approves Two New Indications for First-Line Use of Rituxan(R) (Rituximab) in Patients With Non-Hodgkin's Lymphoma
- Phase II Study Demonstrates That ONTAK(R) Benefits Patients With Relapsed/Refractory T-Cell Non-Hodgkin's Lymphoma
- PCBs, furans may factor in risk of non-Hodgkin lymphoma
- Monoclonal Anti-CD 20 Antibody Used in Non-Hodgkin's Lymphoma: A Case Study
User Comments (0)

RSS Feeds